Isabelle Plantier
Isabelle Plantier publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Chronic Lymphocytic Leukemia Research.
- World rank
- #1,160,844 of 7,710,434 ranked researchers
- Rank in France
- #53,691 of 324,115
- Works
- 71
- Citations
- 4.7k
- Citations per work
- 66.2
What does Isabelle Plantier research?
Isabelle Plantier's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4969.7%
- Medicine4969.7%
- Everything else1622.3%
- Life Sciences68.0%
- 1Hematology34% of their works
- 2Genetics15% of their works
- 3Public Health, Environmental and Occupational Health9% of their works
- 4Molecular Biology8% of their works
- 5Oncology6% of their works
- 6Pathology and Forensic Medicine5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
- Lymphoma Diagnosis and Treatment
- Hematopoietic Stem Cell Transplantation
Which keywords describe Isabelle Plantier's research?
The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Minimal Residual Disease, Rituximab, Acute Lymphoblastic Leukemia and Childhood Cancer.
- Graft-versus-Host Disease
- Lymphoma
- International Myeloma Working Group
- Myelofibrosis
- Imatinib
- Chronic Lymphocytic Leukemia
- Childhood Cancer
- Rituximab
- Acute Myeloid Leukemia
- Hematopoietic Stem Cells
- Prognostic Factors
- AML
- Minimal Residual Disease
- Acute Lymphoblastic Leukemia
- BCR-ABL
- Genomic Aberrations
- JAK2 Mutation
- Diagnosis Criteria
- Classification
- Bone Marrow Niche
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors683 topics
- Hematopoietic Stem Cells422 topics
- AML361 topic
- Acute Myeloid Leukemia361 topic
- Minimal Residual Disease302 topics
- Rituximab242 topics
- Acute Lymphoblastic Leukemia181 topic
- Childhood Cancer181 topic
- BCR-ABL141 topic
- Chronic Lymphocytic Leukemia141 topic
- Genomic Aberrations141 topic
- Imatinib141 topic
- JAK2 Mutation141 topic
- Myelofibrosis141 topic
- Diagnosis Criteria121 topic
- International Myeloma Working Group121 topic
- Classification101 topic
- Lymphoma101 topic
- Bone Marrow Niche61 topic
- Graft-versus-Host Disease61 topic
Where does Isabelle Plantier work?
Isabelle Plantier's main affiliation in the publication record is Centre Hospitalier de Roubaix, France.
How many publications and citations does Isabelle Plantier have?
OpenAlex counts 71 works and 4,700 citations for Isabelle Plantier, an h-index of 22, ranking #1,160,844 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Isabelle Plantier. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.